Next, we investigated the relationship between clinicopathological parameters and the expression to evaluate the prognostic factors, which demonstrated that remarkable enrichment of MELK, EZH2, and NF-κB was associated with higher grade gliomas, basal ganglia/brainstem, and heterogeneous MRI enhancement (Table S2). This evidence concerns the gene EZH2 and glioma.